SLC18A3
protein-codingsolute carrier family 18 member A3, the group of Solute carrier family 18
Gene summary
This gene is a member of the vesicular amine transporter family. The encoded transmembrane protein transports acetylcholine into secretory vesicles for release into the extracellular space. Acetylcholine transport utilizes a proton gradient established by a vacuolar ATPase. This gene is located within the first intron of the choline acetyltransferase gene. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~2.4 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0014983
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0014983
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014983
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0100101
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0014983
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Musculoskeletal
Intervention: Musculoskeletal
Rationale: Early diagnosis and management has been described as beneficial, as individuals have been reported as responding to medical management (with pyridostigmine)
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to SLC18A3 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_003055.3. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 99 | 2 | 107 | ||
| missense | 2 | 179 | 8 | 3 | 192 | |
| nonsense | 2 | 2 | ||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | 2 | 4 | |||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 0 | 6 | 188 | 107 | 5 | 306 |
Highest pathogenic variant AF is 0.00008345052
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_003046.2 | 1 | MANE Select | |
| Ensembl | ENSP00000363229.3 | 1 | MANE Select |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Synaptic vesicle cycle - Homo sapiens (human)
- Cholinergic synapse - Homo sapiens (human)
- Sympathetic Nerve Pathway (Pre- and Post- Ganglionic Junction)
- Synaptic Vesicle Pathway
- Vesicle-mediated transport
Biological Process
- drug transmembrane transport
- neurotransmitter secretion
- organic cation transport
- membrane organization
- ammonium transmembrane transport
Molecular Function
- acetylcholine transmembrane transporter activity
Cellular Component
- plasma membrane
- integral component of membrane
- AP-1 adaptor complex
- AP-2 adaptor complex
- clathrin-coated vesicle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000374115
- Coding exons
- 1
- Length
- 2419
- Individuals with no LoFs
- 0
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 0
- Defined
- 0
- p
- 0.00
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.145 | 311 | 318 | 0.977 | 0.0000151 | 3292 |
| Missense (PolyPhen) | 112 | 131.78 | 0.84989 | 1433 | ||
| Synonymous | -2.63 | 190 | 149 | 1.27 | 0.00000768 | 1236 |
| Loss of Function | 2.33 | 2 | 9.90 | 0.202 | 4.26e-7 | 108 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0 | 0.0 | absent |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0 | 0.0 | absent |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Involved in acetylcholine transport into synaptic vesicles. {ECO:0000269|PubMed:8071310}.;
Intolerance Scores
- LoFtool
- 0.523
- RVIS EVS
- -0.75
- RVIS percentile EVS
- 13.58
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.571
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |